Literature DB >> 32206894

Relations between disease status and body composition in pediatric inflammatory bowel disease.

Saurabh Talathi1, Pooja Nagaraj1, Traci Jester1, Jeanine Maclin1, Taylor Knight2, Margaux J Barnes3.   

Abstract

To evaluate the effect of remission status on physical activity and body composition in pediatric patients with inflammatory bowel disease (PIBD) and healthy peers. Single-center cohort study, including 54 PIBD patients and 33 healthy peers. During the initial study visit, a brief demographic questionnaire, physical activity questionnaire completed by participants, and instructions on recording dietary intake were given. Physicians completed the Physician Global Assessment (PGA) for disease severity. Medical chart abstraction was done to obtain disease variables of interest. DEXA scan completed 1 week later to obtain information on body composition. Variables of interest were compared between the three groups (IBD-Remission, IBD-Active, and healthy controls) using an ANOVA or Chi-square test as appropriate. IBD patients were older than controls, reported lower quality of life (73.9 vs. 80.9), and engaged in less MVPA (195.4 versus 361.1). The IBD-Active group had a significantly lower lean body mass, bone mineral density, and time spent in MVPA compared to the IBD-Remission group and healthy controls. IBD-Remission group had a significantly lower percentage of biologic use (55% vs. 87%) and comorbidities (26% vs. 44%) compared to IBD-active group. IBD-remission group also had a lower fat mass percentage. In this study, we report significantly favorable LBM, BMD, and time spent in MVPA in patients with IBD in remission compared to those not in remission with the former demonstrating a body composition resembling that of healthy peers.
Conclusion: While an improvement in BMD was observed with remission, the scores were still lower than controls. What is Known: • Body composition deficits in pediatric inflammatory bowel disease are common and some persist despite achievement of remission leading to long term outcomes including osteopenia and osteoporosis. • Weight restoration in patients with pediatric IBD is primarily explained by gains in fat mass without similar gains in lean mass. What is New: • While an improvement in bone mineral density was observed, the achievement of remission significantly improves affects physical activity and body composition in pediatric inflammatory bowel disease. • However, some parameters of body composition do not reach levels comparable to healthy peers.

Entities:  

Keywords:  Inflammatory bowel disease; Pediatrics; Physical activity; Quality of life

Year:  2020        PMID: 32206894     DOI: 10.1007/s00431-020-03629-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  34 in total

Review 1.  Inflammatory bowel disease.

Authors:  Sarah R Glick; Ryan S Carvalho
Journal:  Pediatr Rev       Date:  2011-01

Review 2.  Inflammatory bowel disease.

Authors:  Jeffrey S Hyams
Journal:  Pediatr Rev       Date:  2005-09

Review 3.  Current directions in IBD therapy: what goals are feasible with biological modifiers?

Authors:  William J Sandborn
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

4.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

Authors:  Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

Review 5.  Inflammatory Bowel Disease in Children and Adolescents.

Authors:  Michael J Rosen; Ashish Dhawan; Shehzad A Saeed
Journal:  JAMA Pediatr       Date:  2015-11       Impact factor: 16.193

Review 6.  Update on nutritional status, body composition and growth in paediatric inflammatory bowel disease.

Authors:  Rebecca J Hill
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 7.  Crohn's and colitis in children and adolescents.

Authors:  Andrew S Day; Oren Ledder; Steven T Leach; Daniel A Lemberg
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

8.  Premature subclinical atherosclerosis in pediatric inflammatory bowel disease.

Authors:  Marina Aloi; Luciana Tromba; Giovanni Di Nardo; Anna Dilillo; Emanuela Del Giudice; Elisa Marocchi; Franca Viola; Fortunata Civitelli; Alberto Berni; Salvatore Cucchiara
Journal:  J Pediatr       Date:  2012-05-10       Impact factor: 4.406

9.  Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.

Authors:  Eric I Benchimol; Charles N Bernstein; Alain Bitton; Matthew W Carroll; Harminder Singh; Anthony R Otley; Maria Vutcovici; Wael El-Matary; Geoffrey C Nguyen; Anne M Griffiths; David R Mack; Kevan Jacobson; Nassim Mojaverian; Divine Tanyingoh; Yunsong Cui; Zoann J Nugent; Janie Coulombe; Laura E Targownik; Jennifer L Jones; Desmond Leddin; Sanjay K Murthy; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2017-04-18       Impact factor: 10.864

Review 10.  Treating children with inflammatory bowel disease: Current and new perspectives.

Authors:  Graziella Guariso; Marco Gasparetto
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

View more
  3 in total

1.  Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition in Patients with Ulcerative Colitis and Crohn's Disease.

Authors:  Arshdeep Singh; Vandana Midha; Ramit Mahajan; Shruti Verma; Chandan Kakkar; Jasmine Grover; Dharmatma Singh; Ramandeep Kaur; Abhishek Masih; Namita Bansal; Catherine Wall; Ajit Sood
Journal:  Dig Dis Sci       Date:  2022-09-05       Impact factor: 3.487

2.  Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.

Authors:  Chiara Tortora; Alessandra Di Paola; Mara Creoli; Maura Argenziano; Massimo Martinelli; Erasmo Miele; Francesca Rossi; Caterina Strisciuglio
Journal:  Inflamm Bowel Dis       Date:  2022-08-01       Impact factor: 7.290

Review 3.  Bone Health in Pediatric Patients with IBD: What Is New?

Authors:  Rebecca J Gordon; Catherine M Gordon
Journal:  Curr Osteoporos Rep       Date:  2021-06-22       Impact factor: 5.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.